Nov 7, 2022
- Nov 6, 2023
The Role of Neonatal Fc Receptor (FcRn) Blocking Therapeutics in the Management of Patients with Generalized Myasthenia Gravis

Claim your credit

Already have an Account? Log In
Don’t have an account? Register Today

Login to take this course.

This course is available for logged in users only. Please login or register to take the course.

Related Courses

Multiple Sclerosis
A Scientific and Practical Guide to the Administration and Monitoring of FcRn Blockers for...
Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeuti...
Optimal Contemporary Management of Hypertrophic Cardiomyopathy: The Importance of Early Di...